Drug Shortage Report for TARO-MONTELUKAST

Last updated on 2018-08-23 History
Report ID 41756
Drug Identification Number 02389517
Brand name RAN-MONTELUKAST
Common or Proper name RAN-MONTELUKAST
Company Name SUN PHARMA CANADA INC
Market Status MARKETED
Active Ingredient(s) MONTELUKAST
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-03-05
Actual start date 2018-03-05
Estimated end date
Actual end date 2018-08-17
Shortage status Resolved
Updated date 2018-08-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2018-08-23 French Compare
v6 2018-08-23 English Compare
v5 2018-03-22 French Compare
v4 2018-03-22 English Compare
v3 2018-03-06 English Compare
v2 2018-03-05 French Compare
v1 2018-03-05 English Compare

Showing 1 to 7 of 7